An improved labelling technique for monitoring microcrack growth in compact bone. by O\u27Brien, Fergal J et al.
Royal College of Surgeons in Ireland
e-publications@RCSI
Anatomy Articles Department of Anatomy
1-4-2002
An improved labelling technique for monitoring
microcrack growth in compact bone.
Fergal J. O'Brien
Royal College of Surgeons in Ireland, fjobrien@rcsi.ie
David Taylor
Trinity College Dublin
T Clive Lee
Royal College of Surgeons in Ireland
This Article is brought to you for free and open access by the Department
of Anatomy at e-publications@RCSI. It has been accepted for inclusion in
Anatomy Articles by an authorized administrator of e-publications@RCSI.
For more information, please contact epubs@rcsi.ie.
Citation
O'Brien FJ, Taylor D, Lee TC. An improved labelling technique for monitoring microcrack growth in compact bone. Journal of
Biomechanics. 2002; 35(4)523–526.
— Use Licence —
Attribution-Non-Commercial-ShareAlike 1.0
You are free:
• to copy, distribute, display, and perform the work.
• to make derivative works.
Under the following conditions:
• Attribution — You must give the original author credit.
• Non-Commercial — You may not use this work for commercial purposes.
• Share Alike — If you alter, transform, or build upon this work, you may distribute the resulting work only
under a licence identical to this one.
For any reuse or distribution, you must make clear to others the licence terms of this work. Any of these
conditions can be waived if you get permission from the author.
Your fair use and other rights are in no way affected by the above.
This work is licenced under the Creative Commons Attribution-Non-Commercial-ShareAlike License. To
view a copy of this licence, visit:
URL (human-readable summary):
• http://creativecommons.org/licenses/by-nc-sa/1.0/
URL (legal code):
• http://creativecommons.org/worldwide/uk/translated-license
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/anatart/22
REVISION 1 
 
 
TECHNICAL NOTE 
 
 
An improved labelling technique for monitoring microcrack growth in compact bone 
 
 
Fergal J. O’Brien a,b,  David Taylor b, T. Clive Lee a,b* 
 
aDepartment of Anatomy, Royal College of Surgeons in Ireland, 
St Stephen’s Green, Dublin 2, Ireland 
 
bDepartment of Mechanical and Manufacturing Engineering, 
Trinity College, Dublin 2, Ireland 
 
 
 
 
 
 
 
*Corresponding author: 
Clive Lee 
Dept. of Anatomy 
Royal College of Surgeons in Ireland 
123 St. Stephens Green 
Dublin 2 
Ireland  
Tel: +353-1-402-2264;  
Fax: +353-1-402-2355. 
E-mail: tclee@rcsi.ie 
 
 
 
 
 
 
 
 
Keywords: microcrack, propagation, chelating, fluorochrome, chromatography 
 
 
 
 
 
Abstract 
 
 
Fatigue-induced damage plays an important role in bone remodelling and in the 
formation of stress and fragility fractures.  Recently a technique has been developed (Lee 
et al, 2000a) which allows microcrack growth in trabecular bone to be monitored by the 
application of a series of chelating fluorochromes, however some limitations were 
identified with the process.  The aims of this study were to refine the method of detection 
using these agents in order to determine the optimal sequence of application and the 
optimal concentrations which allowed all the agents to fluoresce equally brightly using 
UV epifluorescence.  A chemical analysis process, ion chromatography, followed by 
validation tests on bone samples showed that the optimal sequence of application and 
concentration of each agent was alizarin complexone (0.0005M) followed by xylenol 
orange (0.0005M), calcein (0.0005M) and calcein blue (0.0001M).  A fifth agent, 
oxytetracycline was excluded from the study after recurring problems were found with its 
ability to chelate exposed calcium when applied in sequence with the other agents.  This 
work has developed a sequential labelling technique, which allows for microcrack 
propagation during fatigue testing of bone specimens to be monitored without the 
problem of chelating agent substitution occurring. 
 
 
 
 
1. Introduction 
 
Fatigue-induced microdamage acts as a stimulus for bone remodelling (Martin and Burr, 
1982;  Burr et al, 1985; Burr and Martin, 1993; Mori and Burr, 1993; Prendergast and 
Taylor, 1994; Martin, 2000) and contributes to fragility fractures  (Schaffler et al, 1995; 
Lee et al, 2000b).    Microcracks have been stained using basic fuchsin (Frost, 1960; Burr 
and Stafford, 1990; Burr and Hooser, 1995; Lee et al, 1998; Huja et al, 1999), but a series 
of stains is required to label microcracks at various stages during their  growth.  We have 
demonstrated microcrack growth in vitro using chelating fluorochromes in sequence (Lee 
et al, 2000a), but substitution of one agent by another made measurement imprecise 
(O’Brien et al, 1998).  The aims of this study were to measure the affinity of each of five 
chelating agents for Ca2+ ions and to determine the optimal sequence and concentration 
of these agents for labelling the growth of surface scratches in compact bone. 
 
2. Material and Methods 
Optimal Sequence  
The levels of free calcium in a solution of calcium chloride before and after the 
introduction of each chelating agent were measured using ion chromatography (Haddad 
and Jackson, 1990). Samples were separated on a Dionex system which incorporates a 
pump, cation-trap pre-column and a cation micro membrane suppressor (Dionex, 
Sunnyvale, Ca).  The separation of calcium cations was accomplished in a 15 minute 
analysis run with a Dionex IonPac CS-14 column (4 mm x 250 mm) using 1 x 10-2M 
methane sulphonic acid as mobile phase and suppressed conductivity detection. The 
sample loop size was 50 µL and the flow rate was 1.0 ml/minute. Calcium chloride 
concentration was 1 x 10-3 M and each of the five chelating agents, alizarin complexone 
(A), calcein blue (B), xylenol orange (X) (all from Aldrich Chemical Co., Milwaukee, 
Wi., USA), calcein (C) (Sigma Chemical Co., St. Louis, Mo., USA) and oxytetracycline 
(O) (Bimeda Ltd, Dublin) was injected separately at a concentration of 5 x 10-4 M.  The 
chelating agents were ranked in order of decreasing affinity for calcium and this sequence 
was then tested on bone specimens. 
 
Fresh bovine tibiae were obtained from a meat wholesalers, soft tissue was removed and 
the bone stored at -20oC until required.  Longitudinal sections of cortical bone from the 
mid-diaphysis were cut into beams using a band saw and polished using emery paper.  A 
5 mm line was scratched on the surface of each beam using a ruler and compass point and 
the specimen was immersed in a vial containing a 5 x 10-4 M aqueous solution of a single 
chelating agent and placed in a vacuum desiccator for 4 hours to ensure maximum 
penetration of the surface scratches by each chelating agent.  The specimen was then 
washed in de-ionised water, a second 5mm line scratched parallel to the first and the 
specimen immersed in 5 x 10-4  M aqueous solution of a second chelating agent in the 
vacuum desiccator for 4 hours.  This protocol was repeated using two, three, four and five 
agent sequences.  Five tests were carried out using each sequence.  The bone specimens 
were then analysed using UV (λ=365 nm) epifluorescence (Rahn, 1977) and green 
(λ=568 nm) epifluorescence at X50 and X125 magnifications (Nikon. Optiphot, Japan) 
(Lee et al, 2000a).  Images were captured using a CCD colour video camera (Optronics, 
Goleta CA) and HP PIII personal computer (Hewlett Packard, France) and measured 
using Scion Image software (Scion Corp., MA).   The length of scratch over which dye 
substitution occurred was measured and then graded as follows: 0 (nil); 1 (1-20% - the 
second dye displaced 1-20% of the first); 2 (21-40%); 3 (41-60%);  4 (61-80%);  5 (81-
100%).   
 
Optimal Concentration   
Sequence testing was conducted using 5 x 10-4 M solutions, the lowest concentration at 
which all agents fluoresced clearly and chromatograms could be obtained.  Using the 
optimal four-agent sequence, a second series of scratch tests was carried out to compare 
the 5 x 10-4  M solutions with an in vivo dosage regime devised to ensure that all agents 
appeared equally bright using ultraviolet epifluorescence microscopy  (Rahn, 1977) 
(Table 1).  Five scratch tests using each regime were compared and the degree of 
substitution and clarity of each agent assessed.   
 
3. Results 
 
Figure 1 shows the free calcium peaks obtained in a chromatogram before and after the 
injection of alizarin into calcium chloride solution.  Table 2 summarises the average 
chromatogram peak height and peak area, which are a measure of strength of the signal 
for the calcium chloride standard solution, and in the presence of each chelating agent.  
The calcium affinity of the chelating agents is inversely related to the height and area of 
the second peak.  From this we deduced that the order of affinity for calcium is (from 
greatest to least): A-X-B-C-O. 
 
Scratch tests were carried out using chelating agents applied in this order.  With A and X 
present, both agents fluoresced red and were difficult to differentiate.  However when C 
was applied, it fluoresced green and X now fluoresced bright orange and was clearly 
distinct from A.  Calcein blue followed by calcein resulted in greater substitution (Grade 
3) than C followed by B (Grade 1).  The concentration of B was then reduced in stages, 
firstly to 2.5 x 10-4 M and then to 1 x 10-4 M until the degree of substitution was 
negligible.  Oxytetracycline was problematic as there was Grade 4 substitution of B and 
Grade 1 substitution of X and C by this agent.  This could not be rectified by altering the 
sequence or concentration and so O was excluded from the study.  The revised four stain 
protocol A-X-C-B, using 5 x 10-4  M concentrations of A, X and C and B at 1 x 10-4  M, is 
shown in Figure 2.  All four scratched regions can be clearly distinguished from each 
other and from the surrounding bone matrix and substitution is negligible.  When this 
revised sequence, A-X-C-B, was used with the in vivo dosage regime (Rahn, 1977), A 
and X were difficult to distinguish from each other and calcein blue showed Grade 1 
substitution of both A and C.  
 
4. Discussion 
 
This study has established a sequence of application for the chelating agents which 
minimises substitution of one agent by a subsequent one.  The results obtained from ion 
chromatography tests provide a sequence of chelating agents based on affinity for free 
calcium in a solution of calcium chloride.  This sequence was then applied to bone, using 
surface scratches as a model for microcracks.  This regime was more effective in 
sequentially labelling surface scratches than the concentrations recommended by Rahn 
(1977) (Table 1) for in vivo labelling of bone formation.  This labelling regime can be 
applied in sequence to bone samples undergoing mechanical testing to monitor 
microcrack propagation at different intervals during testing.  Figure 3 shows an example 
of a propagating compressive fatigue microcrack stained with X and C.  This image is 
shown at different exposure times and colour levels, which allows the agents to be 
distinguished from each other. 
  
This study refines a technique for sequentially labelling microcrack growth in bone (Lee 
et al, 2000a; O’Brien et al, 2000; Arthur and Gibson, 2000).  By applying the agents at 
different intervals during a mechanical fatigue test, it may be possible to learn more about 
microcracks, their effect on the fatigue behaviour of bone, their interaction with the 
bone’s microstructure and the processes by which they initiate and grow. 
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Fig. 1 Chromatogram obtained on injection of alizarin complexone (5 x 10-4M) into a 
calcium chloride concentration of 1 x 10-3M.  The first peak in the chromatogram (5 
mins) is known as the solute retention time and is the time it takes for the components to 
travel along the columns.  It displays the amount of free calcium present in the solution 
before chelation has taken place.  The second peak (11.7 mins) is the time it takes for the 
calcium peak to elute following chelation.  It shows the maximum amount of free 
calcium left after chelation has occurred.  Measurements of both peak height and peak 
area were carried out. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Fig. 2 Most efficient 4 agent sequence, from top to bottom: alizarin complexone 
(0.0005M), xylenol orange (0.0005M), calcein (0.0005M) followed by calcein blue 
(0.0001M).  All 4 stains are clearly distinct from each other and from the surrounding 
autofluorescent bone. Scale bar=200 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Fig. 3 Example of a propagating microcrack during fatigue testing in compression. It is 
initially stained with xylenol orange, showing it to have been formed during the first 
10,000 cycles, and then stained with calcein which indicates crack growth between 
10,000 and 50,000 cycles. Fig 3(a) shows the crack viewed at high red levels in order to 
show the part stained with xylenol orange more clearly.  Fig 3(b) shows it at high green 
levels to show the calcein-stained part more clearly. Fig 3(c) shows the same image at 
balanced colour levels.  Scale bar=100 µm. 
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Table 1  Comparison of in vivo dosage concentrations (Rahn, 1977) and concentrations 
used in ion chromatography tests. 
 
 
 Group R (Rahn, 1977) Group C  
Chelating Agent DOSAGE 
(mg/kg) 
CONCENTRATION Ion Chromatography 
Calcein blue 
Xylenol orange 
Calcein (green) 
Alizarin complexone (red) 
Oxytetracycline (yellow) 
30 
90 
10 
30 
30 
0.0000712 M 
0.000016 M 
0.0000933 M 
0.00012 M 
0.00006 M  
0.0005 M 
0.0005 M 
0.0005 M 
0.0005 M 
0.0005 M 
 
 
Table 2  The average height and area of the calcium peak for each of the chelating agents 
investigated along with the calcium standard (1 x 10-3M).   
 
CHELATING AGENT Mean Height Of Ca2+ Peak Average Area of Ca2+ Peak 
Calcium chloride 
Alizarin complexone 
Xylenol orange 
Calcein blue 
Calcein 
Oxytetracycline 
32.45 
14.59 
28.56 
29.73 
30.67 
31.76 
13076154543 
549684922 
1072856912 
1154869484 
12203869425 
12895983615 
 
